5-HT1B and 5-HT1D receptor agonists (triptans) are known to be effective in migraine pharmacotherapy, whereas the influence of numerous polymorphisms in 5-HT1A, 5-HT1B, 5-HT2A and 5-HT2C in this disease is still being investigated. The gene discussed is HTR1B; the disease is migraine disorder.